Outcomes for adults with type 1 diabetes referred with severe hypoglycaemia and/or referred for islet transplantation to a specialist hypoglycaemia service

Hormone and Metabolic Research

Volumn 36, Issue , 2014, Pages 9-15

  Byrne, M L ^a   Hopkins, D ^b   Littlejohn, W ^b   Beckford, R ^b   Srinivasan, P ^b   Heaton, N ^b   Amiel, S A ^a   Choudhary, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

islet transplantation; pancreas transplantation; severe hypoglycaemia; type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTINUOUS GLUCOSE MONITORING; CONTINUOUS INFUSION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MALE; PANCREAS ISLET TRANSPLANTATION; TREATMENT OUTCOME; COMPLICATION; DIABETES MELLITUS, TYPE 1; METABOLISM; PATIENT REFERRAL; SPECIALIZATION;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; REFERRAL AND CONSULTATION; SPECIALIZATION; TREATMENT OUTCOME;

EID: 84909954089     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1394455     Document Type: Article

References (27)

1. Seaquist ER, Anderson J., Childs B., Cryer P., Dagogo-Jack S., Heller SR, Rodriguez H., Rosenzweig J., Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care: 2013; 36 1384 1395
2. McCrimmon RJ, Frier BM. Hypoglycaemia, the most feared complication of insulin therapy. Diabete Metab: 1994; 20 503 512
3. Geddes J., Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med: 2008; 25 501 504
4. Hopkins D., Lawrence I., Mansell P., Thompson G., Amiel S., Campbell M., Heller S. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care: 2012; 35 1638 1642
5. Choudhary P., Parrott NR, Birtles L., Rutter MK. Islet cell transplantation: current status in the UK. Practical Diabetes: 2012; 29 280 285
6. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med: 2008; 25 765 774
7. Garg S., Brazg RL, Bailey TS. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther: 2012; 14 205 209
8. Barton FB, Rickels MR, Alejandro R., Hering BJ, Wease S., Naziruddin B., Oberholzer J., Odorico JS, Garfinkel MR, Levy M., Patton F., Berney T., Secchi A., Messinger S., Senior PA, Maffi P., Possett A., Stock P., Kaufman DB, Luo X., Kandeel F., Cagliero E., Turgeon NA, Witkowski P., Naji A., O'Connell PJ, Greenbaum C., Kudva YC, Brayman KL, Aull MJ, Larsen C., Kay TWH, Fernnandez LA, Vantyghem M-C, Bellin M., Shapiro J. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care: 2012; 35 1436 1445
9. Brooks AM, Walker N., Aldibbiat A., Hughes S., Jones G., de havilland J., Choudhary P., Huang GC, Parrott N., Mcgowan NWA, Casey J., Mumford L., Barker P., Burling K., Hovorka R., Walker M., Smith RM, Forbes S., Rutter MK, Amiel S., Rosenthal MJ, Johson P., Shaw JAM. Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations. Am J Transplant: 2013; 13 3236 3243
10. UK Hypoglycaemia Study Group Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia: 2007; 50 1140 1147
11. DVLA At a glance guide to the current medical standards of fitness to drive for medical professionals. 2013; 2014
12. CITR Collaborative Islet Transplant Registry Seventh Annual Report. 2011; 2014
13. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant: 2005; 19 433 455
14. Bott S., Bott U., Berger M., Mühlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia: 1997; 40 926 932
15. Gruessner AC, Sutherland DE, Gruessner RW. Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant: 2012; 17 100 105
16. Choudhary P., Geddes J., Freeman JV, Emery CJ, Heller SR, Frier BM. Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabetic Med: 2010; 27 666 672
17. Weinstock RS, Xing D., Maahs DM, Michels A., Rickels MR, Peters AL, Bergenstal RM, Harris B., Dubose SN, Miller KM, Beck RW. T1D Exchange Clinic Network. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab: 2013; 98 3411 3419
18. NHS Blood and Transplant Organ Donation and Transplantation Activity Data: United Kingdom. 2014; 2014
19. NICE Guidelines IPG257: Allogeneic Pancreatic Islet Cell Transplantation for Type 1 Diabetes Mellitus. 2008; 2014
20. Health and Social Care Information Centre National Diabetes Audit 2011-2012 - Report 1: Care Processes and Treatment Targets. 2013
21. White HD, Goenka N., Furlong NJ, Saunders S., Morrison G., Langridge P., Paul P., Ghatak A., Weston PJ. The U.K. service level audit of insulin pump therapy in adults. Diabet Med: 2014; 31 412 418
22. Ly TT, Nicholas JA, Retterath A., Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs. standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA: 2013; 310 1240 1247
23. Choudhary P., Ramasamy S., Green L., Gallen G., Pender S., Brackenridge A., Amiel SA, Pickup JC. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care: 2013; 36 4160 4162
24. Little SA, Leelarathna L., Walkinshaw E., Tan HK, Chapple O., Lubina-Solomon A., Chadwick TJ, Barendse S., Stocken DD, Brennand C., Marshall SM, Wood R., Speight J., Kerr D., Flanagan D., Heller SRE, Evans ML, Shaw JA. Recovery of Hypoglycemia Awareness in Long-Standing Type 1 Diabetes: A Multicenter 2×2 Factorial Randomized Controlled Trial Comparing Insulin Pump With Multiple Daily Injections and Continuous With Conventional Glucose Self-Monitoring (HypoCOMPaSS). Diabetes Care: 2014; 37 2114 2122
25. de Zoysa N., Rogers H., Stadler M., Gianfrancesco C., Beveridge S., Britneff E., Choudhary P., Elliot J., Heller S., Amiel SA. A Psychoeducational Program to Restore Hypoglycemia Awareness: The DAFNE-HART Pilot Study. Diabetes Care: 2014; 37 863 866
26. Smith CB, Choudhary P., Pernet A., Hopkins D., Amiel SA. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit. Diabetes Care: 2009; 32 1196 1198
27. Dunn JT, Cranston I., Marsden PK, Amiel SA, Reed LJ. Attenuation of amygdala and frontal cortical responses to low blood glucose concentration in asymptomatic hypoglycemia in type 1 diabetes: a new player in hypoglycemia unawareness? Diabetes: 2007; 56 2766 2773